UNAUDITED SUMMARIZED QUARTERLY FINANCIAL INFORMATION (Tables)

12 Months Ended

Dec. 31, 2018

Quarterly Financial Information Disclosure [Abstract]

Schedule of Unaudited Summarized Quarterly Financial Information

						Net Income (Loss) Attributable to Amedisys, Inc. Common Stockholders (1)
	Revenue		Net Income (Loss) Attributable to Amedisys, Inc.			Basic			Diluted
2018
1st Quarter	$	399.3	$	27.2		$	0.80		$	0.79
2nd Quarter	411.6		33.3			1.00			0.98
3rd Quarter	417.3		31.4			0.99			0.96
4th Quarter	434.4		27.5			0.86			0.84
	$	1,662.6	$	119.3		$	3.64		$	3.55
2017
1st Quarter	$	364.7	$	15.1		$	0.45		$	0.44
2nd Quarter (2)	374.9		4.5			0.13			0.13
3rd Quarter	373.7		14.6			0.43			0.42
4th Quarter (3)	398.0		(3.8		)	(0.11		)	(0.11		)
	$	1,511.3	$	30.3		$	0.90		$	0.88

(1) Because of the method used in calculating per share data, the quarterly per share data may not necessarily total to the per share data as computed for the entire year.

(2) During the second quarter of 2017, we incurred certain costs associated with the Securities Class Action Lawsuit settlement. Net of income taxes, the costs amounted to $18.0 million for the three-month period ended June 30, 2017.

(3) During the fourth quarter of 2017, we recorded a charge of $21.4 million, net of income taxes as the result of the enactment of H.R. 1 (Tax Cuts and Jobs Act).